Skip to main content

Bray Jesse K's Form 4 filing

Maverick Merger Sub 2, LLCCOOP · filed Mar 4, 2024

Accession no.
0000933136-24-000023
Filed
Mar 4, 2024
Trade date
Feb 29-Mar 1, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.79M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bray Jesse KCIK 0001543932Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 29, 2024Common StockSSaleDisposed−25,000$71.61F2−$1,790,250366,051Indirect
Feb 29, 2024Common StockGGiftDisposed−6,420$0.00$0359,631Indirect
Mar 1, 2024Common StockFTax withholdingDisposed−92,310$71.46−$6,596,472.6792,104Direct
Mar 1, 2024Common StockFTax withholdingDisposed−19,254$71.28−$1,372,425.12772,850Direct
Mar 1, 2024Common StockAGrant or awardAcquired+50,856$0.00$0823,706Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 1, 2024Common StockAGrant or awardAcquired+50,856–F7–50,856Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price; the shares were sold in multiple transactions at prices ranging from $71.15 to $73.13, inclusive. Reporting Person, on behalf of the Trust, undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F7

Represents a grant of a target number of performance share units ("PSUs") which are eligible to vest and be settled into shares of Common Stock in an amount between 0% and 200% of the target based on achievement of relative total shareholder return and annualized tangible book value growth performance vesting criteria over a period of three years from January 1, 2024 through December 31, 2026, with 100% of the PSUs eligible to vest on the later of (a) the date Issuer's Compensation Committee certifies the achievement of the performance hurdles and (b) March 1, 2027.

Referenced by the price of 1 transaction in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)